Cancer
Recent research on gastric cancer peritoneal metastasis (GCPM) has identified significant trends and hotspots in the field, highlighting the need for precision and personalized treatment. GCPM is a challenging and difficult-to-treat condition, with a low 5-year survival rate. The study analyzed 2416 publications on GCPM from 2004 to 2024, revealing
Cancer
Researchers at Taizhou Hospital of Zhejiang Province presented a case study where a patient with a history of lung cancer was misdiagnosed with an avulsion fracture, when in fact, the patient had a pathological fracture due to metastatic cancer. The case underscores the importance of maintaining a high index of
Cancer
Researchers at the Department of Medical Oncology conducted an open-label, single-arm Phase II trial to evaluate the effectiveness and safety profile of first-line immune checkpoint inhibitors combined with chemotherapy in pulmonary sarcomatoid carcinoma (PSC). The study found that the combination of immune checkpoint inhibitors with chemotherapy showed robust efficacy alongside
Cancer
Researchers at University Teknologi MARA in Malaysia have made significant discoveries about the potential of excipients, typically considered inactive additives, to be used as anti-cancer therapeutics at the nanoscale. According to recent literature, excipient nanoparticles can stimulate reactive oxygen species production, trigger apoptosis, and regulate metastasis, making them a promising
Cancer
New research from Taibah University has made a significant breakthrough in cancer treatment, utilizing lipid nanoparticles to enhance the efficacy and reduce the toxicity of doxorubicin. This innovative approach has shown promising results in both in vitro and in vivo studies, demonstrating improved bioavailability and reduced off-target toxicity. The synthesized
Antineoplastic agents
A recent study published in The Lancet Global Health has revealed alarming statistics about cancer medication defects in sub-Saharan Africa. Researchers from the University of Notre Dame collected dosage information from a dozen hospitals and 25 pharmacies across Ethiopia, Kenya, Malawi, and Cameroon, testing 251 cancer drugs. The study found
Cancer
The federal government of Nigeria has launched a blood-based test, known as Oncoseek, for the early detection of nine high-mortality cancers. The test can identify breast, colorectal, esophageal, liver, lung, lymphoma, ovarian, pancreatic, and stomach cancer. The launch took place during the maiden National Workshop of the National Cancer Control
Cancer
Latvia's Balvi Municipality offers state-funded cancer screenings to residents of certain age groups, including breast, cervical, bowel, and prostate cancer screenings. These tests are provided free of charge and are designed to detect diseases at an early stage in apparently healthy people. The screenings are organized through invitation
Cancer
Research conducted by Shandong University in Jinan, People's Republic of China, explored the interrelationships between parental burnout, sibling relationship quality, and quality of life in children with cancer. The study used a cross-sectional design and enrolled 218 children with cancer and their parents in three tertiary hospitals in
Cancer
Researchers at Fujian University of Traditional Chinese Medicine have discovered that baicalin, a compound found in Chinese herbal medicines, can reverse multidrug resistance in human hepatocellular carcinoma (HCC) cells. The study found that baicalin increased the accumulation of chemotherapy drugs and induced apoptosis and autophagy in resistant HCC cells by
Cancer
A study published in Frontiers in Oncology has explored the potential of personalized cancer screening guided by genomic information. The research, conducted by a team of scientists from the Kanagawa Cancer Center in Yokohama, Japan, suggests that current approaches to cancer prevention face challenges due to the low risk associated
Cancer
Researchers from the Chinese University of Hong Kong have made a breakthrough discovery in understanding the role of the DMD gene in gastric cancer. According to a recent study published in Cancer Cell International, the DMD gene is significantly downregulated in gastric cancer cells and tissues, leading to altered calcium
